Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Exp Clin Psychopharmacol. 2011 Sep 19;20(1):28–39. doi: 10.1037/a0025237

Table 3.

Descriptive statistics for sleep outcomes across Period 1 and Period 2 of sleep.

Placebo Zolpidem Placebo Zolpidem
Baseline phase Baseline phase Chronic phase Chronic phase Significance
Mean (SE) Mean (SE) Mean (SE) Mean (SE)
Sleep Period 1
  Initial sleep latency (min) 12.04 3.72 8.29 2.42 12.45 2.28 8.06 1.46 -
  Wake after sleep onset (min) 1.14 0.43 2.33 2.05 5.64 2.37 0.72 0.41 -
  Total sleep time (min) 42.55 3.00 44.74 2.35 38.55 3.68 45.91 2.59 -
  Sleep efficiency* 0.78 0.06 0.82 0.04 0.69 0.06 0.84 0.03 Z>P
  Stage 1 (%)* 0.16 0.06 0.07 0.02 0.18 0.05 0.07 0.01 Z<P
  Stage 2 (%)+ 0.33 0.04 0.43 0.06 0.50 0.06 0.44 0.07 1<2
  slow wave sleep (%) 0.51 0.06 0.48 0.07 0.32 0.07 0.47 0.06 -
  REM sleep (%) 0.00 0.00 0.02 0.02 0.00 0.00 0.02 0.02 -
Sleep Period 2
  Initial sleep latency (min)* 10.58 2.29 2.71 0.70 22.04 9.43 2.31 0.61 Z<P
  Wake after sleep onset (min) 28.84 8.15 26.13 6.80 32.71 7.64 35.94 9.56 -
  Total sleep time (min) 387.30 8.18 393.13 8.22 372.12 10.34 389.53 9.47 -
  Sleep efficiency 0.91 0.02 0.93 0.02 0.87 0.03 0.91 0.02 -
  Stage 1 (%)* 0.09 0.02 0.05 0.01 0.09 0.02 0.06 0.01 Z<P
  Stage 2 (%)* 0.49 0.02 0.53 0.03 0.50 0.02 0.54 0.02 Z>P
  slow wave sleep (%)+ 0.13 0.02 0.13 0.02 0.10 0.02 0.11 0.02 1>2
  REM sleep (%) 0.30 0.02 0.29 0.02 0.31 0.02 0.29 0.01 -
  REM latency (min) 55.29 10.03 68.77 11.80 58.30 9.53 56.40 10.84 -

Note. SE = standard error. Significance: P = Placebo, Z = Zolpidem, 1 = baseline phase, 2 = chronic phase.

Symbols:

dash (-) = not significant;

asterisk (*) = main effect of drug condition;

plus sign (+) = main effect of phase.